We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

By HospiMedica International staff writers
Posted on 18 Feb 2026

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. More...

Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization efforts. Microneedle array patches offer a painless, self-administered alternative, but delivering live virus through these patches has posed challenges, including incomplete dosing and loss of viral viability. Researchers have now developed a 3D-printing approach that enhances microneedle vaccine delivery and preserves live virus activity.

Researchers at the Institute of Industrial Science, The University of Tokyo (Tokyo, Japan) have improved microneedle array patches by integrating a 3D-printed backing layer composed of tiny plastic pillars. During fabrication, the pillar layer is inserted into the patch mold so that the viral solution forms dissolvable needles at the tip of each pillar. When applied to the skin, the microneedles dissolve and release the vaccine, enabling minimally invasive and potentially self-administered immunization.

Researchers found that incorporating the 3D-printed pillar structure reduced drying time during fabrication, preserving a greater proportion of live virus compared with conventional microneedle patches. In mouse models, the pillar-guided patches generated specific immune responses that protected against lethal SARS-CoV-2 infection. The results, published in Scientific Reports, demonstrate improved vaccine stability and efficacy using the modified design.

The pillar-guided microneedle platform offers a stable, room-temperature vaccine delivery option that could expand immunization access in regions without reliable refrigeration. Its painless and self-administrable design may also facilitate rapid deployment during outbreaks. Researchers suggest that this approach could be adapted for other live-virus vaccines, supporting scalable and efficient vaccine distribution worldwide.

“Our findings show that pillar-guided MAPs are a promising platform for delivering virus vaccines,” said Kotaro Shobayashi, lead author of the study.

Related Links:
IIS, University of Tokyo 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.